Literature DB >> 16983574

Leptomeninges as a site of relapse in locally controlled, diffuse pontine glioma with review of literature.

Suruchi Singh1, Ritu Bhutani, Rakesh Jalali.   

Abstract

CASE REPORT: Leptomeningeal involvement in diffuse intrinsic brain stem gliomas is rarely diagnosed clinically and in majority of the instances diagnosed only on postmortem examination. We report two cases of diffuse pontine glioma diagnosed clinicoradiologically and treated with conventional radiotherapy. OBSERVATIONS: On follow-up, both patients showed clinical features suggestive of meningeal spread although imaging for pontine tumor showed stable disease. Leptomeningeal disease in the spine was confirmed on imaging and in one case by cerebrospinal fluid examination also. During the follow-up of patients with pontine glioma, the possibility of leptomeningeal involvement must be borne in mind.

Entities:  

Mesh:

Year:  2006        PMID: 16983574     DOI: 10.1007/s00381-006-0168-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  10 in total

1.  Atypical external hydrocephalus with visual failure due to occult leptomeningeal dissemination of a pontine glioma. Case report.

Authors:  Andrew Tarnaris; Richard J Edwards; Stephen P Lowis; Ian K Pople
Journal:  J Neurosurg       Date:  2005-03       Impact factor: 5.115

Review 2.  Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination.

Authors:  B Donahue; J Allen; J Siffert; M Rosovsky; R Pinto
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

3.  A staging system for brain stem gliomas.

Authors:  F Epstein
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

4.  Pediatric brain stem gliomas.

Authors:  P Littman; P Jarrett; L T Bilaniuk; L B Rorke; R A Zimmerman; D A Bruce; S C Carabell; L Schut
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

5.  Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy.

Authors:  E C Halperin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-07       Impact factor: 7.038

6.  Primitive neuroectodermal tumors of the brainstem: investigation of seven cases.

Authors:  D Zagzag; D C Miller; E Knopp; J P Farmer; M Lee; S Biria; A Pellicer; F J Epstein; J C Allen
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

7.  Brain stem glioblastoma with multiple large cyst formation and leptomeningeal dissemination in a 4-year-old girl.

Authors:  Rie Kanai; Masaru Tasaka; Hitoshi Sejima; Nobue Uchida; Akinobu Nakano; Yasuhiko Akiyama; Toshiki Yamasaki; Seiji Yamaguchi
Journal:  Brain Dev       Date:  2005-01       Impact factor: 1.961

8.  Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases.

Authors:  Junichi Yoshimura; Kiyoshi Onda; Ryuichi Tanaka; Hitoshi Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-08       Impact factor: 1.742

9.  Brainstem glioma: clinical manifestations of meningeal gliomatosis.

Authors:  R J Packer; J Allen; S Nielsen; C Petito; M Deck; B Jereb
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

10.  Brain stem gliomas: an autopsy study of 25 cases.

Authors:  R V Mantravadi; R Phatak; S Bellur; E J Liebner; R Haas
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

  10 in total
  1 in total

1.  Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.

Authors:  Patricia A Baxter; Qi Lin; Hua Mao; Mari Kogiso; Xiumei Zhao; Zhigang Liu; Yulun Huang; Horatiu Voicu; Sivashankarappa Gurusiddappa; Jack M Su; Adekunle M Adesina; Laszlo Perlaky; Robert C Dauser; Hon-chiu Eastwood Leung; Karin M Muraszko; Jason A Heth; Xing Fan; Ching C Lau; Tsz-Kwong Man; Murali Chintagumpala; Xiao-Nan Li
Journal:  Acta Neuropathol Commun       Date:  2014-12-20       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.